Total Payments
$11,320
2024 Payments
$2,216
Companies
48
Transactions
659
Medicare Patients
2,571
Medicare Billing
$606,640
Payment Breakdown by Category
Food & Beverage$11,089 (98.0%)
Education$146.74 (1.3%)
Other$79.60 (0.7%)
Gifts$4.66 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,089 | 655 | 98.0% |
| Education | $146.74 | 2 | 1.3% |
| Entertainment | $79.60 | 1 | 0.7% |
| Gift | $4.66 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,725 | 159 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,097 | 119 | $0 (2024) |
| Janssen Biotech, Inc. | $1,795 | 106 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $872.68 | 54 | $0 (2024) |
| Romark Laboratories, LC | $286.85 | 18 | $0 (2019) |
| PFIZER INC. | $259.03 | 16 | $0 (2024) |
| Braintree Laboratories, Inc. | $228.42 | 13 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $222.97 | 16 | $0 (2021) |
| GENZYME CORPORATION | $216.13 | 10 | $0 (2024) |
| Celgene Corporation | $202.40 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,216 | 122 | ABBVIE INC. ($546.09) |
| 2023 | $1,317 | 74 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($409.41) |
| 2022 | $1,572 | 91 | Janssen Biotech, Inc. ($501.43) |
| 2021 | $1,943 | 114 | AbbVie Inc. ($597.19) |
| 2020 | $783.16 | 51 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($232.03) |
| 2019 | $1,061 | 65 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($315.41) |
| 2018 | $1,505 | 89 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($426.45) |
| 2017 | $923.51 | 53 | AbbVie, Inc. ($219.92) |
All Payment Transactions
659 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Immunology | ||||||
| 12/05/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/04/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: LIVER DISEASE | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/21/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/17/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 453 | 12,330 | $1.4M | $263,939 |
| 2022 | 14 | 528 | 9,023 | $1.2M | $217,719 |
| 2021 | 14 | 545 | 682 | $488,132 | $53,776 |
| 2020 | 15 | 1,045 | 1,710 | $450,462 | $71,206 |
Total Patients
2,571
Total Services
23,745
Medicare Billing
$606,640
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 23 | 10,200 | $530,400 | $176,715 | 33.3% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 14 | 1,680 | $388,080 | $44,295 | 11.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 59 | 59 | $84,134 | $11,239 | 13.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 89 | 89 | $133,186 | $7,685 | 5.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 28 | $18,760 | $3,643 | 19.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 48 | 49 | $57,456 | $3,184 | 5.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 14 | 27 | $27,000 | $2,474 | 9.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 39 | $9,243 | $2,456 | 26.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 34 | 34 | $33,328 | $2,353 | 7.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 13 | 13 | $14,210 | $2,118 | 14.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 25 | 25 | $84,165 | $1,808 | 2.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 21 | $7,308 | $1,766 | 24.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $21,000 | $1,721 | 8.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 24 | 36 | $8,028 | $1,533 | 19.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 16 | $3,792 | $949.28 | 25.0% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 17 | 6,900 | $358,800 | $119,684 | 33.4% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 15 | 1,580 | $364,980 | $45,290 | 12.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 67 | 68 | $96,968 | $13,293 | 13.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 94 | 95 | $127,742 | $8,269 | 6.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 44 | 44 | $27,500 | $6,542 | 23.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 32 | 57 | $57,000 | $5,544 | 9.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 52 | $18,096 | $4,301 | 23.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 60 | 61 | $68,564 | $3,763 | 5.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 47 | $11,139 | $2,808 | 25.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 30 | 31 | $29,203 | $2,435 | 8.3% |
About Dr. Robert Loudon, M.D
Dr. Robert Loudon, M.D is a Gastroenterology healthcare provider based in Alabaster, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487608881.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Loudon, M.D has received a total of $11,320 in payments from pharmaceutical and medical device companies, with $2,216 received in 2024. These payments were reported across 659 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($11,089).
As a Medicare-enrolled provider, Loudon has provided services to 2,571 Medicare beneficiaries, totaling 23,745 services with total Medicare billing of $606,640. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Alabaster, AL
- Active Since 05/20/2006
- Last Updated 12/04/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1487608881
Products in Payments
- XIFAXAN (Drug) $1,684
- STELARA (Biological) $1,679
- LINZESS (Drug) $564.54
- RINVOQ (Biological) $531.89
- ENTYVIO (Biological) $501.14
- Humira (Biological) $393.84
- DUPIXENT (Biological) $379.06
- CREON (Drug) $352.76
- TRULANCE (Drug) $332.68
- HUMIRA (Biological) $325.16
- XELJANZ (Drug) $242.83
- Alinia Tablets 500mg 30 count bottle (Drug) $230.45
- Mavyret (Drug) $217.60
- UCERIS (Drug) $202.63
- ZEPOSIA (Drug) $188.38
- VIBERZI (Drug) $168.83
- MAVYRET (Drug) $164.93
- Amitiza (Drug) $150.37
- OCALIVA (Drug) $150.15
- Entyvio (Biological) $144.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Alabaster
John Day, M.d, M.D
Gastroenterology — Payments: $12,338
Gastroenterology $12,338
Brian Brunson, Md, MD
Gastroenterology — Payments: $8,818
Gastroenterology $8,818
Robert Marks, M.d, M.D
Gastroenterology — Payments: $8,475
Gastroenterology $8,475
Bradley Rubery, M.d, M.D
Gastroenterology — Payments: $4,483
Gastroenterology $4,483
Leonard Ou-Tim, Md, MD
Gastroenterology — Payments: $62.80
Gastroenterology $62.80